Analyst firms · Barclays · COR

Barclays COR price target and rating history

Cencora Inc. (COR) · Health Care

Barclays rates Cencora Inc. (COR) Overweight with a $400 price target, as of its latest action on Dec 9, 2025. It has published 5 rating actions on COR since August 2021, including 1 upgrade and 0 downgrades. Across 4 firms with a COR price target in the last 12 months, the median target is $400. Barclays's target matches it.

Current rating
Overweight
Price target
$400
Median target, all firms
$400
Actions on COR
5

Barclays price target on COR

$400$262$12320222023202420252026
Barclays price target on COR, each point a stated target, August 2021 to December 2025.

Every Barclays rating on COR

How other firms rate COR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsSector Perform$330Aug 19, 2026
William BlairMkt PerformApr 28, 2026
Morgan StanleyOverweight$400Jan 29, 2026
JefferiesBuy$440Jan 22, 2026
BarclaysOverweight$400Dec 9, 2025

Questions about Barclays and COR

What is Barclays's price target for COR?
Barclays's latest stated price target for Cencora Inc. (COR) is $400, from its action on Dec 9, 2025.
What is Barclays's rating on COR?
Barclays rates COR Overweight, a bullish rating, as of Dec 9, 2025.
When did Barclays last change its view on COR?
On Dec 9, 2025, Barclays starts coverage at Overweight, price target $400.
How does Barclays's COR target compare with other analysts?
Across 4 firms with a COR price target in the last 12 months, the median target is $400. Barclays's target matches it.

More COR rating histories

All Barclays ratingsCOR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.